Novo Nordisk Overview
Novo Nordisk Target Price
Analysts' 12-month price predictions for NVO.
Get informed when a big investor buys or sells
+ FollowShare Price
$50.43
Average Target Price
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-02-05 | BMO Capital | $45 |  10.8% downside |  |
| 2026-01-26 | BMO CapitalEvan Seigerman | $57 |  13% upside | |
| 2025-12-10 | HSBC | $54 | 7.1% upside | |
| 2025-12-03 | Morgan StanleyThibault Boutherin | $42 | 16.7% downside | |
| 2025-11-25 | BMO CapitalEvan Seigerman | $46 | 8.8% downside | |
| 2025-10-14 | BMO CapitalEvan Seigerman | $55 | 9.1% upside | |
| 2025-10-01 | HSBC | $70 | 38.8% upside | |
| 2025-09-29 | Morgan Stanley | $47 | 6.8% downside | |
| 2025-07-31 | HSBC | $57 | 13% upside | |
| 2025-07-23 | Truist FinancialJailendra Singh | $48 | 4.8% downside | |
| 2024-10-17 | BMO CapitalEvan Seigerman | $156 | 209.3% upside | |
| 2024-09-11 | Cantor FitzgeraldLouise Chen | $160 | 217.3% upside | |
| 2024-08-08 | BMO CapitalEvan David Seigerman | $160 | 217.3% upside | |
| 2024-06-10 | Argus ResearchJasper Hellweg | $160 | 217.3% upside | |
| 2024-05-30 | Goldman SachsJames Quigley | $156 | 209.3% upside | |
| 2024-04-12 | BMO CapitalEvan David Seigerman | $163 | 223.2% upside | |